Fumiko Ladd Chino/bumpintheroad.us
Apr 25, 2025, 08:19
Fumiko Ladd Chino: It’s important to publish negative trials. AI cannot solve EVERYthing
Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X:
“Emails to academic medical oncologists with info about genomically matched therapeutic clinical trials for patients with tumor progression based on AI interpretation of imaging reports did NOT increase trial enrollment.
It’s important to publish negative trials. AI cannot solve EVERYthing.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 18:14
May 11, 2025, 18:05
May 11, 2025, 17:07
May 11, 2025, 16:57
May 11, 2025, 16:49